# Retension (RTSN) — News

RTSN · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/rtsn/news

## Recent headlines

- [Retension Pharmaceuticals opens at $10, IPO at $12](https://www.ainvest.com/news/retension-pharmaceuticals-opens-10-ipo-12-2610) — AInvest Wire, Oct 9, 2026
  Retension Pharmaceuticals (NASDAQ: RTN) began trading on October 9, 2026, with an initial public offering (IPO) price of $12 per share. The stock opened at $10, reflecting a modest start for the biopharmaceutical company focused on developing novel therapies for chronic diseases. The IPO raised…

---

Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).